Page last updated: 2024-08-25

voriconazole and Fungemia

voriconazole has been researched along with Fungemia in 109 studies

Research

Studies (109)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (0.92)18.2507
2000's55 (50.46)29.6817
2010's46 (42.20)24.3611
2020's7 (6.42)2.80

Authors

AuthorsStudies
Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB1
Aurbach, U; Cornely, O; Seifert, H; Stefanik, D1
Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH1
Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL1
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS1
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS1
Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G1
Marchione, G; Midena, G; Parrozzani, R1
Moncada, D; Ramírez, I1
Abu Sitta, E; Elsaghir, H; Hollingshead, C; Luttmann, K1
Ding, CH; Faiz, MA; Khaithir, TMN; Saarah, WR; Wahab, AA1
Bourgeois, T; Lagrou, K; Lodewyck, T; Nulens, E; Reynders, M; Van Praet, J; Verbeke, V1
Chen, YC; Chou, CH; Ho, MW; Kuo, SH; Lee, CH; Lin, SY; Lu, PL1
Chen, Y; Ding, L; Wang, K; Wang, P; Wu, Z; Xu, H; Xu, Z1
Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG1
Ambica, R; Chunchanur, SK; Joseph, J; Nagarathnamma, T; Ramamurthy, K; Rudramurthy, SM; Vineetha, KR1
Nguyen, JK; Pourciau, CY; Schady, D; Schlichte, MJ1
Ishigaki, S; Kitazawa, T; Ota, Y; Seo, K; Yoshino, Y1
Keechilattu, P; Philip, A; Raju, DS; Reghu, R; Sugunan, A1
Al-Hatmi, AM; Arastehfar, A; Bakhtiari, M; Boekhout, T; Daneshnia, F; Fang, W; Groenewald, M; Hagen, F; Liao, W; Pan, W; Sadati, SK; Sharifi-Mehr, H; Zomorodian, K1
Fujinami, H; Iida, S; Ishida, T; Ito, A; Komatsu, H; Kusumoto, S; Marumo, Y; Narita, T; Oshima, Y; Ri, M; Sasaki, H; Tachita, T; Yoshida, T1
Cadelis, G; Diallo, K; Gallois, JC; Gandon, F; Hoen, B; Lefevre, B; Nicolas, M1
Bacci, F; Bertuzzi, C; Bonifazi, F; Cavo, M; Cricca, M; De Cicco, G; Lewis, RE; Paolini, S; Sassi, C; Stanzani, M; Sutto, E1
Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A1
Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H1
Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó1
Barbui, A; Boccadoro, M; Brunello, L; Bruno, B; Ferrando, F; Festuccia, M; Gay, F; Giaccone, L; Maffini, E; Serra, R; Talamo, E1
Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F1
Chen, L; Cheng, X; Dong, H; Dong, Y; Sun, J; Wang, T; Wang, X; Xie, J; Xing, J; Zhu, H1
Ramos, MG; Rodríguez, ZC1
Ahmed, Y; Albrecht, H; Siddiqui, W; Weissman, S1
da Silva, CM; de Lima Neto, RG; de Morais, VL; Domingos, Ide F; Gonçalves, SS; Leite, EP; Macêdo, DP; Neves, RP; Parahym, AM; Rolim Neto, PJ1
Chan, JF; Chen, JH; Guo, D; Lau, SK; Pan, Y; Tsang, CC; Wang, H; Woo, PC; Xiao, Y; Xu, Y; Yue, N; Zhao, Y1
Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X1
Alem, N; Karabıçak, N1
Non, LR; Pande, A; Romee, R; Santos, CA1
Cai, S; Cao, C; Liang, H; Ouyang, Y1
Akyürek, N; Aydın Kaynar, L; Aygencel, G; Güzel Tunçcan, Ö; Kalkancı, A; Özkurt, ZN; Ülküden, B1
Chakrabarti, A; Chakravarty, C; Dutta, S; Gopalakrishnan, R; Jessani, LG; Jillwin, J; Roy, U; Rudramurthy, SM1
Aurbach, U; Cornely, OA; De Hoog, S; Demeter, J; Durán Graeff, L; Hamprecht, A; Kindo, A; Racil, Z; Seidel, D; Vehreschild, MJ; Wisplinghoff, H; Ziegler, M1
Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A1
Kisac, P; Krcmery, V; Liskova, A1
Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T1
Jadoul, M; Labriola, L; Swinne, D; V, B1
Fanci, R1
Joshi, A; Khattry, N; Shah, MS; Singh, R; Umesh, S1
Akova, M; Beyazit, Y; Purnak, T; Sahin, GO; Shorbagi, A1
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J1
Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B1
Segal, BH; Sherif, R1
Gabrielian, A; Hariprasad, SM1
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F1
Accoceberry, I; Gabriel, F; Noel, T1
Ciecko, SC; Scher, R1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS1
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M1
Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A1
Doroftei, B; Mareş, M; Năstasă, V; Ramona, FM; Stefanache, A1
Hamoud, S; Hayek, T; Keidar, Z1
Bedini, A; Cavrini, F; Cocchi, S; Codeluppi, M; De Ruvo, N; Di Benedetto, F; Gennari, W; Gerunda, GE; Grottola, A; Guaraldi, G; Rumpianesi, F; Venturelli, C1
Hayashi, T; Hosokawa, K; Ishiyama, K; Kondo, Y; Mochizuki, K; Nakao, S; Ohata, K; Okumura, H; Sugimori, N; Takami, A; Yamazaki, H1
Catania, MR; De Domenico, G; Panellis, D; Pulcrano, G; Rossano, F1
Maack, KH; Tarp, B1
Danielsen, R; Einarsdóttir, HM; Gottfredsson, M1
Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S1
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J1
Garbino, J; Kolarova, L; Lew, D; Ondrusova, A; Rohner, P1
Kullberg, BJ; Ostrosky-Zeichner, L; Oude Lashof, AM; Rex, JH1
Denning, D; Guiver, M; Sambatakou, H1
Bliss, JM; Gigliotti, F; Wellington, M1
Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C1
Chow, E; Moore, T; Nielsen, K1
Baboor, M; Diaz, MC; Fica, A; Luppi, M; Olivares, R; Saez, L; Vasquez, P1
Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ1
Rubin, ZA; Somani, J1
Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA1
Chadwick, EG; Guzman-Cottrill, JA; Zheng, X1
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK1
Irving, H; Labrom, R; Nissen, M; O'Regan, P; Siebert, D; Whyte, M1
Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M1
Jang, GJ; Kim, KS; Lee, WK; Shin, WS1
Jagirdar, J; Scott, RS; Sutton, DA1
Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M1
Bishara, J; Peled, N; Samra, Z; Yardeni, M1
Alexander, BD; Long, GD; Miller, JL; Perfect, JR; Schell, WA1
Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S1
Argaud, L; Martin, O; Mohammedi, I; Piens, MA; Robert, D; Thiebaut, A1
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D1
Chamilos, G; Kontoyiannis, DP1
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC1
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T1
Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF1
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H1
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G1
Carratalà, J; Garcia-Vidal, C1
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L1
Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A1
Blumenkranz, MS; Egbert, P; Jain, A; McCulley, TJ; Moshfeghi, DM1
Alvarez Lerma, F1
Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA1
Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J1
Hoban, DJ; Karlowsky, JA; Zhanel, GG1
Chandrasekar, PH; Cutright, J; Manavathu, E1
Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS1

Reviews

14 review(s) available for voriconazole and Fungemia

ArticleYear
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
    Mycopathologia, 2020, Volume: 185, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2020
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
    Mycoses, 2018, Volume: 61, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2018
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.
    Mycoses, 2019, Volume: 62, Issue:12

    Topics: Adult; Aged; Antifungal Agents; Disease Outbreaks; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Saccharomycetales; Voriconazole

2019
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
    BMJ case reports, 2014, Dec-12, Volume: 2014

    Topics: Amphotericin B; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Female; Fluconazole; Fungemia; Humans; Middle Aged; Mycoses; Risk Factors; Voriconazole; Yeasts

2014
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
    BMC infectious diseases, 2015, Sep-22, Volume: 15

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole

2015
Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cryptococcus; Cytarabine; Dermatomycoses; Echinocandins; Exanthema; Fever; Fungemia; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Male; Micafungin; Opportunistic Infections; Retrospective Studies; Saccharomyces; Salvage Therapy; Trichosporon; Ustilaginales; Vidarabine; Voriconazole; Yeasts

2017
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
    Current opinion in pulmonary medicine, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole

2010
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3

    Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole

2010
Rhodotorula fungemia: two cases and a brief review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2011
Antifungal pharmacotherapy for neonatal candidiasis.
    Seminars in perinatology, 2003, Volume: 27, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
New options for the treatment of invasive fungal infections.
    Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2004
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
    Revista iberoamericana de micologia, 2007, Volume: 24, Issue:2

    Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole

2007
[Role of voriconazole in critically ill patients with invasive mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole

2007

Trials

3 trial(s) available for voriconazole and Fungemia

ArticleYear
Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:5

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Female; Fungemia; Humans; Male; Meningitis, Fungal; Middle Aged; Plasma; Polymorphism, Genetic; Treatment Outcome; Voriconazole; Young Adult

2014
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
    Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole

2005
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2008

Other Studies

92 other study(ies) available for voriconazole and Fungemia

ArticleYear
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia

2007
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5

    Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles

2007
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Dose-Response Relationship, Drug; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2007
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests

2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity

2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation

2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged

2008
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation

2010
Endogenous Trichosporon Asahii Retinitis.
    Ophthalmology, 2022, Volume: 129, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Blast Crisis; Caspofungin; Cerebrospinal Fluid; Child; Drug Therapy, Combination; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Leukemia, Myeloid, Acute; Retinitis; Trichosporonosis; Voriconazole

2022
    BMJ case reports, 2020, Mar-17, Volume: 13, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Carcinoma, Squamous Cell; Fungemia; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Thyroid Neoplasms; Vancomycin; Voriconazole

2020
Trichosporon Asahii fungaemia in an immunocompetent polytrauma patient who received multiple antibiotics.
    The Malaysian journal of pathology, 2020, Volume: 42, Issue:2

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Basidiomycota; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Trauma; Trichosporonosis; Voriconazole

2020
Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
    Mycopathologia, 2020, Volume: 185, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Voriconazole

2020
The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2021, Volume: 120, Issue:9

    Topics: Antifungal Agents; Basidiomycota; DNA, Fungal; Fungemia; Genotype; Humans; Microbial Sensitivity Tests; Trichosporon; Voriconazole

2021
Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient.
    Mycopathologia, 2017, Volume: 182, Issue:7-8

    Topics: Antifungal Agents; Asia; Brain; C-Reactive Protein; Fungemia; Humans; Leukocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Talaromyces; Thoracic Wall; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2017
Outbreak of Pichia kudriavzevii fungaemia in a neonatal intensive care unit.
    Journal of medical microbiology, 2017, Volume: 66, Issue:12

    Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Disease Outbreaks; DNA, Fungal; Drug Resistance, Multiple, Fungal; Female; Fungemia; Humans; Infant; Infant, Premature; Infant, Very Low Birth Weight; Infection Control; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Morbidity; Pichia; Thrombocytopenia; Voriconazole

2017
Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
    Pediatric dermatology, 2018, Volume: 35, Issue:1

    Topics: Antifungal Agents; Antineoplastic Agents; Child; Drug Eruptions; Febrile Neutropenia; Fungemia; Humans; Immunocompromised Host; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon; Trichosporonosis; Voriconazole

2018
Catheter-related bloodstream infection due to Rhodotorula mucilaginosa with normal serum (1→3)-β-D-glucan level.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Female; Fever; Fungemia; Glucans; Humans; Immunocompromised Host; Micafungin; Rhodotorula; Risk Factors; Voriconazole

2018
Chemoport-related Fungemia Caused by Trichosporon asahii.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:3

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheter-Related Infections; Catheters, Indwelling; Dactinomycin; Fungemia; Humans; Immunocompromised Host; Infant; Kidney Neoplasms; Male; Trichosporonosis; Vincristine; Voriconazole

2020
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
    Future microbiology, 2019, Volume: 14

    Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Triazoles; Voriconazole

2019
Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole.
    Internal medicine (Tokyo, Japan), 2019, Aug-01, Volume: 58, Issue:15

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Exophiala; Female; Fungemia; Humans; Lymphoma; Mass Spectrometry; Voriconazole

2019
A case report of fungemia due to Kodamaea ohmeri.
    BMC infectious diseases, 2019, Jul-01, Volume: 19, Issue:1

    Topics: Aged, 80 and over; Antifungal Agents; Candida albicans; Diagnostic Errors; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Microbial Sensitivity Tests; Saccharomycetales; Voriconazole

2019
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
    Journal de mycologie medicale, 2013, Volume: 23, Issue:4

    Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult

2013
[Three cases of fungemia caused by Blastoschizomyces capitatus].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult

2013
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2014
Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:4

    Topics: Antifungal Agents; Antineoplastic Agents; Fungemia; Humans; Male; Middle Aged; Mycoses; Stem Cell Transplantation; Trichoderma; Voriconazole

2014
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult

2015
Acremonium species associated fungemia: a novel pathogen in the immunosuppressed patient.
    Boletin de la Asociacion Medica de Puerto Rico, 2014, Volume: 106, Issue:3

    Topics: Acremonium; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Treatment Outcome; Voriconazole

2014
Invasive infection due to Saprochaete capitata in a young patient with hematological malignancies.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2015, Volume: 46, Issue:2

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Lung; Male; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Radiography, Thoracic; Saccharomycetales; Treatment Outcome; Voriconazole

2015
Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study.
    Journal of clinical microbiology, 2015, Volume: 53, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Base Sequence; Catheter-Related Infections; Catheterization, Central Venous; Catheterization, Peripheral; Child, Preschool; DNA, Ribosomal Spacer; Echinocandins; Female; Fungemia; Hospitalization; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Prospective Studies; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Voriconazole; Yarrowia

2015
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole

2016
Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: A Retrospective Study.
    Mycopathologia, 2017, Volume: 182, Issue:5-6

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Fungemia; HIV Infections; Humans; Infant; Male; Middle Aged; Retrospective Studies; Talaromyces; Treatment Outcome; Voriconazole; Young Adult

2017
[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:4

    Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fatal Outcome; Female; Fungemia; Humans; Leukemia; Lipopeptides; Moths; Mycoses; Opportunistic Infections; Saccharomycetales; Voriconazole; Young Adult

2016
Seven cases of Saccharomyces fungaemia related to use of probiotics.
    Mycoses, 2017, Volume: 60, Issue:6

    Topics: Adult; Aged; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Critical Illness; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; India; Infant, Newborn; Male; Microbial Sensitivity Tests; Multigene Family; Probiotics; RNA, Ribosomal; Saccharomyces boulardii; Saccharomyces cerevisiae; Voriconazole

2017
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
    Mycoses, 2017, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fungemia; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Registries; Saccharomycetales; Voriconazole; Young Adult

2017
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
Voriconazole and posaconazole resistant Candida pelliculosa fungemia after cardiac surgery.
    The Pediatric infectious disease journal, 2009, Volume: 28, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Surgical Procedures; Child; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Infant; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2009
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:12

    Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient.
    Clinical nephrology, 2009, Volume: 71, Issue:3

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheters, Indwelling; Female; Fungemia; Humans; Paecilomyces; Pyrimidines; Renal Dialysis; Triazoles; Voriconazole

2009
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.
    Bone marrow transplantation, 2010, Volume: 45, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Fungemia; Humans; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2010
A novel fungal pathogen under the spotlight--Acremonium spp. associated fungaemia in an immunocompetent host.
    Mycoses, 2011, Volume: 54, Issue:1

    Topics: Acremonium; Antifungal Agents; Female; Fungemia; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2011
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts

2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
    Mycopathologia, 2010, Volume: 170, Issue:3

    Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2010
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2010, Volume: 45, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Functional Laterality; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole

2010
[Rhodotorula glutinis sepsis. A case report].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole

2010
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult

2011
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
    Ear, nose, & throat journal, 2010, Volume: 89, Issue:12

    Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2010
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:7

    Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates.
    Mycopathologia, 2011, Volume: 172, Issue:6

    Topics: Antifungal Agents; Blood; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Romania; Triazoles; Voriconazole; Yeasts

2011
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
    The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:9

    Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole

2011
Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:4

    Topics: Adult; Antifungal Agents; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Liver Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Therapy, Combination; Fatal Outcome; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult

2012
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
    FEMS yeast research, 2012, Volume: 12, Issue:4

    Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole

2012
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
    Ugeskrift for laeger, 2012, Aug-27, Volume: 174, Issue:35

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole

2012
Successful treatment of Candida glabrata myocarditis with voriconazole.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:10

    Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Follow-Up Studies; Fungemia; Humans; Male; Myocarditis; Pyrimidines; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2002
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:2

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2003
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:5

    Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole

2003
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
    Diagnostic microbiology and infectious disease, 2003, Volume: 46, Issue:4

    Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole

2003
Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
    Infection, 2003, Volume: 31, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Sampling Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2003
Voriconazole salvage treatment of invasive candidiasis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2003
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11

    Topics: Adult; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fungemia; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Serologic Tests; Treatment Outcome; Triazoles; Voriconazole

2003
Successful treatment of Acremonium fungemia with voriconazole.
    Mycoses, 2003, Volume: 46, Issue:11-12

    Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2003
Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:12

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2003
Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana.
    Scandinavian journal of infectious diseases, 2003, Volume: 35, Issue:11-12

    Topics: Aged; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Fungemia; Humans; Male; Pyrimidines; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole

2003
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:10

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2004
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
    Infection, 2004, Volume: 32, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole

2004
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-01, Volume: 39, Issue:5

    Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2004
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    American journal of ophthalmology, 2005, Volume: 139, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole

2005
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:4

    Topics: Antifungal Agents; Child; Female; Fungemia; Humans; Immunocompromised Host; Mycetoma; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2005
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:5

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2005
Treatment of candida chorioretinitis with voriconazole.
    Korean journal of ophthalmology : KJO, 2005, Volume: 19, Issue:1

    Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2005
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
    Annals of diagnostic pathology, 2005, Volume: 9, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:9

    Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2005
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.
    Transplantation, 2005, Sep-27, Volume: 80, Issue:6

    Topics: Adolescent; Adult; Candida glabrata; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbial Sensitivity Tests; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2005
Endogenous Phialemonium curvatum endophthalmitis.
    American journal of ophthalmology, 2005, Volume: 140, Issue:4

    Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole

2005
Emergence of Candida albicans fungemia during voriconazole therapy.
    The Journal of infection, 2005, Volume: 51, Issue:3

    Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
    Infection, 2005, Volume: 33, Issue:5-6

    Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole

2005
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2005
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
    Medical mycology, 2005, Volume: 43, Issue:8

    Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole

2005
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Haematologica, 2006, Volume: 91, Issue:2

    Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:5

    Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2006
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2006
[Clinical cases in medical mycology. Case no. 21].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole

2006
Echinocandins for candidemia.
    The New England journal of medicine, 2006, Dec-28, Volume: 355, Issue:26

    Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole

2006
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2006, Nov-16, Volume: 11, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole

2006
Endogenous Scedosporium apiospermum endophthalmitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:9

    Topics: Adult; Antifungal Agents; Aqueous Humor; Biological Availability; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole

2007
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2008
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
    Journal of clinical microbiology, 2008, Volume: 46, Issue:3

    Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2008
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6

    Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole

1999
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2000
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
    Journal of clinical microbiology, 2001, Volume: 39, Issue:9

    Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole

2001